The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Targeted inhibition of IRAK-4 with emavusertib on immune remodeling in metastatic brain melanoma.
 
Christina Von Roemeling
Research Funding - Curis
 
Bently Patrick Doonan
Research Funding - Curis
 
Rylynn Ally Russell
No Relationships to Disclose
 
Tyler V. Elliott
No Relationships to Disclose
 
Erica Matich
No Relationships to Disclose
 
Vincent Archibald
No Relationships to Disclose
 
Lan Hoang-Minh
No Relationships to Disclose
 
Dora Marie Ferrari
Employment - Curis
Leadership - Curis
 
Jamison Hoffman
Employment - Curis
 
Duane Anthony Mitchell
Stock and Other Ownership Interests - iOncologi
Consulting or Advisory Role - Immunomic Therapeutics; Oncorus; Tocagen
Research Funding - Curis; Immunomic Therapeutics
Patents, Royalties, Other Intellectual Property - Annias Therapeutics, Inc.; Celldex; Immunomic Therapeutics; iOncologi
Travel, Accommodations, Expenses - Immunomic Therapeutics
Other Relationship - iOncologi